Acute rheumatic fever
Girum asirat (MD)
June 2023
Wachemo university
Introduction
Multi system disease resulting from autoimmune reaction to infection with
group A streptococus
Is a disease of poverty
Crowdedness and poor hygiene leads to increased transmission of the bacteria
Mainly disease of children ( 5 – 14 yrs)
Rare after 30 yrs
Adolescents and adults affected by recurrence rather than primary episode
1/31/2024
2
11:31 AM
Pathogenesis
Etiology : infection of the URT with group A, B- hemolytic streptococcus
- any strain has the potential to cause it
- repeated pharyngitis is required to prime the immune system before
the development of ARF
Immune reaction : Autoimmune reaction leads to damage of host tissue because
of cross reactivity between antigens of the organism and host tissue
1/31/2024
3
11:31 AM
Clinical features
Latent period : 3 wks ( 1- 5 wks )
Most preceding pharyngeal infection are subclinical
Heart involvement :
60% of patients with ARF develop rheumatic heart disease
it is pancarditis
damage of heart valves is the hallmark
Mitral valve is almost always affected
Aortic valve may be involved with the mitral valve but isolated aortic valve
involvement is rare
Early valve damage leads to regurgitant murmur
With recurrent episode leaflet thickening , scarring , calcification and valvular
stenosis may develop
1/31/2024
4
11:31 AM
Clinical features contd..
Pericarditis , friction rub , small effusion on echocardiography
Rarely pleuritic chest pain from adjacent involvement of the pleura
Myocardial involvement is almost never responsible in itself for cardiac failure
but can affect electrical conduction pathways leading to PR lnterval
prolongation and softening of S1
1/31/2024
5
11:31 AM
Clnical features contd…
Joint involvement :
-to qualify as a major manifestation joint involvement must be arthritic (
with evidence of inflammation)
-it is a migratory arthritis moving from one joint to the other in period of
hours
- it involves large joints ( ankle , knee , hip , elbow)
- arthralgia with out signs of inflammation may occur with similar pattern as
arthritis but only qualify as minor criteria
-Highly responsive to NSAIDS : joint involvement that stays more than one to
two days after starting salicylates is unlikely to be due to ARF
1/31/2024
6
11:31 AM
Clnical features contd…
Chorea : sydenhams chorea usually occur in the absence of other manifestations
-usually in females
-abnormal body movement : eg . Darting movement of the tongue and
extremity
-usually resolve in 6 weeks
1/31/2024
7
11:31 AM
Clnical features contd…
Skin :
-erythema marignatum
-subcutaneous nodules
Other features :
-fever
1/31/2024
8
11:31 AM
Laboratory investigations
CBC : leukocytosis
ESR and CRP : raised
ASO titer or anti DNAse B titer
Throat culture
Rapid antigen tests for streptococcus antigens
ECG : PR prolongation
ECHO : new or worsening regurgitant murmur
: minimal pericardial fluid
1/31/2024
9
11:31 AM
2002/2003 WHO criteria for the
diagnosis of rheumatic fever and
rheumatic heart disease
Diagnostic categories Criteria
Primary episode of rheumatic fever 2 major or 1 major + 2 minor +
evidence of GA strept infecion
Recurrent attack of rheumatic fever 2 major or 1 major + 2 minor +
in a patient without estabilished RHD evidence of GA strept infecion
Reccurent rheumatic fever in a 2 minor + evidence of streptococcal
patient with already estabilished RHD infection
1/31/2024
10
11:31 AM
Chorea and indolent carditis No other criteria or evidence of
strept infection is required
Moderate or high risk
Risk category
Diagnostic Low risk
criteria contd..
Major Carditis both clinical and Carditis ...clinical and
subclinical subclinical
Polyarthritis Polyarthritis
Chorea Monoarthritis
Erythema marginatum Polyarthralgia
Subcutanous nodule Chorea
Subcutanous nodule
Erythema marginatum
Minor Fever 38.5 or more Fever more than 38
Polyarthralgia Monoarthralgia
ESR 60 mm/hr or more ESR 30MM/hr or more
CRP 3mg/dl or more
CRP more than 3mg/dl
Leuckocytosis
Leuckocytosis
Prologed PR interva unless
Prolonged PR interval carditis is used as majior
criteria
ECG : prolonged P - R 1/31/2024
11
interval
11:31 AM
Low risk....ARF prevalence less than or equal to 2/100,000 school age
children
All age rheaumatic heart disease prevalence less than or equal to
1/1000 population
Moderate/high risk..ARF prevalence more than 2/100,000 school age children
All age rheaumatic heart disease prevalence more than 1/1000
Population
Treatment
No treatment for ARF prevents the development
or severity of RHD
Antibiotics :- amoxicillin 500 mg po tid for 10
days
-benzathine penicillin G 1.2 million
international units IM stat
-erythromycin 250 mg po bid for 10 days
for penicillin allergics
1/31/2024
13
11:31 AM
Treatment contd..
Salicylates and NSAIDS :
- treatment of arthritis , arthralgia , and fever once diagnosis is confirmed
-of no value in treatment of carditis or chorea
-Aspirin ( ASA) 80 – 100 mg/kg/day for the first few days up to 2 weeks
When acute symptoms resolve decrease dose to 60 – 80 mg/kg/day for further 2 –
4 weeks
1/31/2024
14
11:31 AM
Treatment contd..
Carditis : conventional therapy for CHF
prednisolone 1-2 mg/kg/day required for only few days up to 3
weeks maximum
Chorea : medication does not alter the duration or out come of chorea
carbamazepine , valproate , haloperidol
1/31/2024
15
11:31 AM
Prognosis of ARF
Untreated ARF stays for 12 weeks
Weekly or 2 weekly follow up of ESR and CRP ( normalize within 4- 6 weeks)
Echo after 1 month to see the progression of carditis
60 % of patients with ARF develop rheumatic heart disease
1/31/2024
16
11:31 AM
Prevention
Primary prevention :
ideal : eliminating risk factors for strept infection which are over
crowdedness and poor hygiene
-if sore throat is treated within 9 days of commencement ARF will be
prevented
1/31/2024
17
11:31 AM
Secondary prevention
-Longterm antibiotic prophylaxis is required for those patients who have
Patient
sustained category
an episode of rheumatic feverDuration of prophylaxis
Patient with out proven For 5 years after last attack
carditis or 18 yrs old which over
comes late
Patient with mild MR or 10 yrs after last attack or
healed carditis till 25 yrs old which ever
comes late
More severe VHD Lifelong
1/31/2024
18
11:31 AM
Valve surgery Life long
secondary prevention contd..
Antibiotic for prophylaxis :
-benzathine penicillin 1.2 million IU every 2- 4 weeks
-erythromycine 250 mg po BID
1/31/2024
19
11:31 AM
Infective
endocarditis
Introduction
IE is infection of the endocardial surface of the heart most commonly on the
valves.
The prototypic lesion is vegetation which is a mass of fibrin platelets ,
microorganisms and inflammatory cells
The intra cardiac effects of IE leads to severe valve insufficiency and CHF
Systemic signs and symptoms also occur through different mechanisms
1/31/2024
21
11:31 AM
Classification of IE Based on
the duration of Illness
1. Acute IE : less common and it affects healthy
native valves
- it is rapidly developing febrile disease
with destruction of valvular structure
- if untreated rapidly progresses to death
in weeks
2. Subacute IE : has insidious course with slowly
progressing valve damage
-usually occurs on already damaged
valves (eg on valves affectes by RHD)
1/31/2024
22
11:31 AM
CLASSIFICATION (BASED ON
PREDISPOSING RISK
1.
FACTORS)
Native valve endocarditis
community acquired
Health care associated (nosocomial) endocarditis: defined as a diagnosis of IE made
more than 72 hours after admission in patients with no evidence of IE on admission, or IE
developing within 60 days of a prior admission when there was a risk factor for
bacteremia or any risk factor for IE during the hospitalization
2. Prosthetic valve endocarditis
3. Endocarditis in IVD abusers
1/31/2024
23
11:31 AM
Epidemiology
Native valve endocarditis is the commonest cause in third world countries
IE especially develops on previously damaged valves(eg. due to RHD ,
degenerative disease )
Prosthetic valve IE and IE in IV drug abusers are concerns of developed
countries
1/31/2024
24
11:31 AM
Etiology
Many species of bacteria and fungi can cause sporadic IE but most of the IE is
caused by certain type of bacteria
Native valve community acquired IE:
-The pathogens vary with the clinical picture of the disease and the portal of
entry
-Oral cavity => Streptococcus viridans
-Skin====== => Staphylococcus
-URT========> HACEK organisms
-GIT=========== => streptococcus bovis
-GUT=========== => enterococci
1/31/2024
25
11:31 AM
Etiology contd..
Prosthetic valve infections : staph aureus or coagulase negative
staphylococci
IV drug abusers : commonly Staph. aureus , but Pseudomonas aureginosa and
candida species can also be incriminated
Nosocomial IE : staph aureus
1/31/2024
26
11:31 AM
1/31/2024
27
11:31 AM
Pathogenesis contd..
IE affects the mitral valve , aortic valve , combined aortic and mitral , and tricuspid
valve and rarely the pulmonic valves in the respective order
The cardiac conditions that leads to the formation of NBTE which are the sites of
infection are MR , AS , AR , VSD and other complex congenital heart diseases
The systemic manifestations of IE are caused due to
embolic phenomenon from the infected thrombus
hematogenous dissemination of infecting organisms
immunologic reaction from ag/ ab deposition
cytokine mediated effects
1/31/2024
28
11:31 AM
Clinical features
Sub acute IE :
is caused by organisms like S . viridans , enterococci , HACEK organisms
The clinical features of sub acute IE are non specific
Fever is typically low grade
is a slowly progressive process characterized by fever , fatigue , anorexia , back pain and
weight loss
Cardiac manifestations are rare or occur late in untreated patients
1/31/2024
29
11:31 AM
Clinical features contd
Acute IE:
is a much more progressive disease
Caused by Staph aureus
The clinical symptoms result from either embolic or intracardiac suppurative complications.
There is an acute onset of high grade fever and chills and rapid onset of CHF
Complications develop with in a week
Because of its short course immunologic phenomenon are not part of acute IE
1/31/2024
30
11:31 AM
Cardiac manifestations :
new regurgitant murmur from valvular damage and rupture of chordae tendinae
congestive heart failure resulting usually from the valvular abnormality or myocarditis
extension of the infection to the adjacent myocardium leads to perivalvular abscess
which may interrupt the normal electrical impulse transmission leading to heart
blocks(arrhythmia)
1/31/2024
31
11:31 AM
Clinical manifestation contd..
Non cardiac manifestations :
hematogenous dissemination of the infecting organism to the skeletal system , GI ,
meninges , kidneys , skin
arterial embolization to the brain , bowel , spleen , extremity resulting in
infarction
immunologic complications: glomerulo nephritis , spenomegaly , oslers nodes
1/31/2024
32
11:31 AM
CLINICAL FEATURES OF IE
1/31/2024
33
11:31 AM
Clinical manifestation contd..
Immunologic manifestaions of IE :
-acute glomerulonephritis
-osler’s nodes
-roth spot
-presence of rheumatoid factor
1/31/2024
34
11:31 AM
Physical examination
Fever
Murmurs
Peripheral lesions of SBE (not common to see currently because of early initiation
of antibiotics) :
petechia
splinter hemorrhage
Clubbing
Splenomegaly
Oslers nodes
Janeway lesions
1/31/2024
35
11:31 AM
NON CARDIAC MANIFESTATIONS OF IE
Janeway lesions: are
macular, blanching,
nonpainful, erythematous
lesions on the palms and
soles
Osler's nodes: are painful,
papulopustular to
violaceous nodular lesions
found in the pulp of
fingers and toes and are
seen more often in
subacute than acute
cases of IE 1/31/2024
11:31 AM
36
PERIPHERAL MANIFESTATIONS OF IE
Roth spots are exudative,
edematous hemorrhagic lesions
of the retina
petechie
Splinter hemorrhage: are
nonblanching, linear reddish-
brown lesions found under the
nail bed
1/31/2024
37
11:31 AM
Non cardiac manifestations
Embolization:
more common in patients with S. aureus IE
vegetations >10 mm in diameter , and infection involving
the mitral valve are independently associated with an
increased risk of embolization
skin, spleen, kidneys, skeletal system, and meninges are
commnly involved
Stroke, Blindness, painful ischemic or frankly gangrenous
extremities, unusual pain syndromes (eg, due to splenic or
renal infarction), hypoxia (due to pulmonary emboli in
right-sided endocarditis) and paralysis (due to embolic
infarction of either the brain or spinal cord)
1/31/2024
38
11:31 AM
Non cardiac manifestations
Neurologic complications:
embolic stroke
acute encephalopathy
Meningoencephalitis
purulent or aseptic meningitis
cerebral hemorrhage (due to stroke or a ruptured mycotic aneurysm)
brain abscess or cerebritis
seizures (secondary to abscess or embolic infarction)
1/31/2024
39
11:31 AM
NON CARDIAC MANIFESTATIONS
Mycotic aneurysm
Renal disease
renal infarction (due to emboli)
drug-induced acute interstitial nephritis
glomerulonephritis (due to deposition of immunoglobulins and
complement in the glomerular membrane)
rarely, renal abscess can occur in patients with IE
Metastatic abscess
Musculoskeletal complications
Complications of surgical and medical therapy 1/31/2024
40
11:31 AM
1/31/2024
41
11:31 AM
INVESTIGATIONS
INFECTIVE ENDOCARDITIS
1/31/2024
42
11:31 AM
BLOOD CULTURE
Blood cultures should be obtained prior to antibiotic therapy
Atleast 3 blood culture sets (2 bottles per set), separated from each
other by 1 h, should be obtained from different venipuncture sites over
24 h
Each bottle should be inoculated with a minimum of 10 mL (and
preferably 20 mL) of blood (the estimated yield of blood cultures in
bacteremic adults increased approximately 3 percent per mL of blood
cultured)
Blood cultures can be taken at any time; they do not need to be
obtained with the appearance of chills or fever
From 5- 15% of patients with IE have negative blood cultures; in 1/3 -
1/2 of these cases, cultures are negative because of prior antibiotic
1/31/2024
11:31 AM
43
exposure
Echocardiography
allows anatomic confirmation of IE, sizing of vegetations, detection of
intracardiac complications, and assessment of cardiac function
TTE
is noninvasive and exceptionally specific
cannot image vegetations <2 mm in diameter
detects vegetations in only 65% of patients with definite clinical endocarditis
TTE is not adequate for evaluating prosthetic valves or detecting intracardiac
complications
TEE
is safe and detects vegetations in >90% of patients with definite IE
initial studies may be false-negative in 6–18% of IE pts
optimal method for the diagnosis of PVE or the detection of myocardial abscess,
valve perforation, or intracardiac fistulae.
1/31/2024
44
11:31 AM
ADDITIONAL TESTS
CXR and ECG
Serologic tests can be used to implicate causally some organisms that are difficult to recover by
blood culture: Brucella, Bartonella, Legionella, and C. burnetii
An elevated ESR and/or CRP
A normochromic normocytic anemia
WBC count may be normal or elevated in patients with subacute presentations of endocarditis;
however, most patients with staphylococcal endocarditis have leukocytosis and some may have
thrombocytopenia
Hyperglobulinemia, cryoglobulins, circulating immune complexes, hypocomplementemia,
elevated rheumatoid factor titers, and false positive serologic tests for syphilis all occur in
some patients
An abnormal U/A, as manifested by microscopic or gross hematuria, proteinuria, and/or pyuria
1/31/2024
RFT, CT/MRI scan 45
11:31 AM
DIAGNOSIS OF IE
1/31/2024
46
11:31 AM
1/31/2024
47
11:31 AM
treatment
Principles antimicrobial antibiotics
Prolonged treatment
Bactericidal
parenteral
1/31/2024
48
11:31 AM
Emperic treatment
Only should be started after 2 sets of blood culture taken
Coverage of streptococci, staph and enterococci must be considered
beta lactam such as penicillin + aminoglycoside, has been shown to be highly
effective in streptococcal and enterococcal endocarditis, and of equivocal
efficacy in patients with staphylococcal endocarditis
penicillin + aminoglycoside, or ceftriaxone+ aminoglycoside for 2wks is highly
effective in streptococcus viridans endocarditis
Nafcillin + aminoglycoside for 2wks has been shown to be effective in patients
with right-sided IE due to S. aureus .
1/31/2024
49
11:31 AM
1/31/2024
50
11:31 AM
ANTIBIOTIC TREATEMENT OF IE
1/31/2024
51
11:31 AM
ANTIBIOTIC TREATEMENT OF IE
1/31/2024
52
11:31 AM
INDICATIONS FOR CARDIAC SURGICAL
INTERVENTION IN IE
1/31/2024
53
11:31 AM
GENERAL MEASURES FOR THE PREVENTION OF IE
Incidence of IE can be reduced by total surgical
correction of some congenital lesions, such as patent
ductus arteriosus, ventricular septal defect, and
pulmonary stenosis
Maintaining good oral hygiene, which decreases the
frequency of bacteremia that accompanies daily
activities, is an important preventive measure
Infections associated with bacteremia must be treated
promptly and, if possible, eradicated before the
involved tissues are incised or manipulated
1/31/2024
54
11:31 AM
CHEMOPROPHYLAXIS
Prophylactic antibiotics are advised only for those patients at highest risk
for severe morbidity or death from endocarditis
Prophylaxis is recommended only for dental procedures wherein there is
manipulation of gingival tissue or the periapical region of the teeth or
perforation of the oral mucosa (including surgery on the respiratory tract)
Although prophylaxis is not advised for patients undergoing GI or GI tract
procedures, it is recommended that effective treatment be given to these
high-risk patients before or when they undergo procedures on an infected
GUT or on infected skin and related soft tissue
1/31/2024
55
11:31 AM
High-Risk Cardiac Lesions for Which Endocarditis
Prophylaxis Is Advised before Dental Procedures
1/31/2024
56
11:31 AM
Antibiotic Regimens for Prophylaxis of Endocarditis
in Adults with High-Risk Cardiac Lesions
1/31/2024
57
11:31 AM